Cost of epilepsy in the United States : a model based on incidence and prognosis.
A model of the clinical course of epilepsy from onset until remission or death has been developed for six prognostic groups, including survival, use and cost of medical care, and time lost from work and housekeeping.
The model has been used to generate preliminary estimates of the lifetime cost of epilepsy for a cohort of persons diagnosed in 1990 in the United States.
The distribution of incident cases among prognostic groups is derived from epidemiologic studies of prognosis in epilepsy.
Direct cost is estimated by multiplying nationally representative unit costs by the expected type and frequency of medical care use.
The latter were derived by an expert panel, based on inferences from existing literature and on their own clinical experiences.
Mots-clés Pascal : Epilepsie, Analyse coût, Economie santé, Homme, Etats Unis, Amérique du Nord, Amérique, Modèle, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie
Mots-clés Pascal anglais : Epilepsy, Cost analysis, Health economy, Human, United States, North America, America, Models, Nervous system diseases, Central nervous system disease, Cerebral disorder
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0161792
Code Inist : 002B17A03. Création : 09/06/1995.